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GOseq GOseq is a method for GO analysis of RNA-seq  data that takes into account the length bias  inherent in RNA-seq
Abstract
We present GOseq, an application for performing Gene Ontology (GO) analysis on RNA-seq data. GO analysis is widely 
used to reduce complexity and highlight biological processes in genome-wide expression studies, but standard 
methods give biased results on RNA-seq data due to over-detection of differential expression for long and highly 
expressed transcripts. Application of GOseq to a prostate cancer data set shows that GOseq dramatically changes the 
results, highlighting categories more consistent with the known biology.
Background
Next generation sequencing of RNA (RNA-seq) gives
unprecedented detail about the transcriptional landscape
of an organism. Not only is it possible to accurately mea-
sure expression levels of transcripts in a sample [1], but
this new technology promises to deliver a range of addi-
tional benefits, such as the investigation of alternative
splicing [2], allele specific expression [3] and RNA editing
[4]. However, in order to accurately make use of the data,
it is vital that analysis techniques are developed to take
into account the technical features of RNA-seq output.
As many of the specific technical properties of RNA-seq
data are not present in previous technologies such as
microarrays, naive application of the same analysis meth-
odologies, developed for these older technologies, may
lead to bias in the results.
In RNA-seq experiments the expression level of a tran-
script is estimated from the number of reads that map to
that transcript. In many applications, the expected read
count for a transcript is proportional to the gene's expres-
sion level multiplied by its transcript length. Therefore,
even when two transcripts are expressed at the same
level, differences in length will yield differing numbers of
total reads. One consequence of this is that longer tran-
scripts give more statistical power for detecting differen-
tial expression between samples [5]. Similarly, more
highly expressed transcripts have a greater number of
reads and greater power to detect differential expression.
Hence, long or highly expressed transcripts are more
likely to be detected as differentially expressed compared
with their short and/or lowly expressed counterparts.
The fact that statistical power increases with the number
of reads is an unavoidable property of count data, which
cannot be removed by normalization or re-scaling. Con-
sequently, it is unsurprising that this selection bias has
been shown to exist in a range of different experiments
performed using different analysis methods, experimen-
tal designs and sequencing platforms [5]. When perform-
ing systems biology analyses, failure to account for this
effect will lead to biased results.
One simple, but extremely widely used, systems biology
technique for highlighting biological processes is gene
category over-representation analysis. In order to per-
form this analysis, genes are grouped into categories by
some common biological property and then tested to find
categories that are over represented amongst the differ-
entially expressed genes. Gene Ontology (GO) categories
are commonly used in this technique and there are many
tools available for performing GO analysis - for example,
EasyGO [6], GOminer [7], GOstat [8], GOToolBox [9],
topGO [10], GSEA [11], DAVID [12] (see supplementary
data 1 in Huang da et al. [12] for a more complete list).
Although these tools have some differences in methodol-
ogy [12], they all rely on similar underlying assumptions
about the distribution of differentially expressed (DE)
genes. Specifically, it is assumed that all genes are inde-
pendent and equally likely to be selected as DE, under the
null hypothesis. It is this assumption that makes the stan-
dard GO analysis methods unsuitable for RNA-seq data
due to the bias in detecting differential expression for
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genes with a high number of reads. It follows then that
when using a standard analysis, any category containing a
preponderance of long genes will be more likely to show
u p  a s  o v e r - r e p r e s e n t e d  t h a n  a  c a t e g o r y  w i t h  g e n e s  o f
average length. Similarly, categories with highly
expressed genes are also more likely to be found as over-
represented than categories of lowly expressed genes.
Having identified this issue, it is possible to compensate
for the effect of selection bias in the statistical test of a
category's enrichment among differentially expressed
genes.
This paper will be concerned with developing a statisti-
cal methodology that enables the application of GO anal-
ysis to RNA-seq data by properly incorporating the effect
of selection bias. Using published RNA-seq data, we will
show that accounting for this effect leads to significantly
different results, which agree much better with previous
microarray studies and the known biology than the
results of an uncorrected analysis.
Results
Because it is so widely used, we choose to focus our cate-
gory testing on GO analysis. The techniques developed
here apply more generally, however, to any analysis that
looks for over-representation of some category of interest
amongst differentially expressed genes. For example,
alternative analyses might look for over-representation of
KEGG (Kyoto Encyclopedia of Genes and Genomes)
pathways, gene sets in the Molecular Signatures Database
[11], or gene lists derived from earlier microarray experi-
ments.
To illustrate the methodology, the GOseq technique
was applied to an experiment examining the effects of
androgen stimulation on a human prostate cancer cell
line, LNCaP [13]. This published data set includes more
than 17 million short cDNA reads obtained for both the
treated and untreated cell line and sequenced on Illu-
mina's 1G genome analyzer. These reads were re-mapped
back to the reference genome and the number of reads
per gene was recorded (see Additional file 1 for details).
Examples of the methodology throughout the paper are
made using this data set and we show that the GOseq
method makes a substantial difference to the results of
the GO analysis, which are more consistent with prior
knowledge of the system.
GO analysis
Standard methods for testing over-representation of a
GO category assume that, under the null hypothesis, each
gene has equal probability of being detected as DE. Under
this assumption, the number of genes associated with a
category that overlap with the set of DE genes follows a
hypergeometric distribution. Hence the GO test can be
conducted using Fisher's exact test, which uses the hyper-
geometric distribution, or Pearson's chi-square test,
which is a computationally convenient approximation
[12]. Because of the existence of selection bias, genes with
more reads are more likely to be detected as DE, violating
the assumption behind the hypergeometric distribution.
Therefore, these standard test distributions should not be
used for GO analysis with RNA-seq data. Instead, we
need a new test that corrects for selection bias.
Selection bias
Transcript length bias will affect GO analysis if the sets of
genes associated with GO categories contain a non-ran-
dom set of genes, with either a preponderance of short or
long genes. To test individual categories for a length dis-
tribution bias, we assessed the length of genes within
7,873 unique GO categories associated with human genes
in the GO consortium database [14]. The length distribu-
tion of the genes in these categories varied widely, with
some categories containing an over-representation of
long genes and some with relatively short genes (Figure
1a). A Mann-Whitney U test (also known as a Wilcoxon
rank-sum test) was performed on each category to test
whether the median length of genes in that GO category
differed from the global median length across all catego-
ries. Figure 1b shows a histogram of the Mann-Whitney
P-values. The clear excess of low P-values indicates the
existence of GO categories with many long or short
genes. Therefore, we expect that a standard analysis of
GO category enrichment among DE genes, which ignores
transcript length, to be significantly affected by the tran-
script length bias inherent to RNA-seq.
The GOseq method
In order to correct for selection bias in category testing,
we propose the following three-step methodology. First,
the genes that are significantly DE between conditions are
identified. The GOseq method works with any procedure
for identifying DE genes. Second, the likelihood of DE as
a function of transcript length is quantified. This is
obtained by fitting a monotonic function to DE versus
transcript length data. Finally, the DE versus length func-
tion is incorporated into the statistical test of each cate-
gory's significance. This final step takes into account the
lengths of the genes that make up each category.
The first step in the GOseq procedure is to determine
which genes are differentially expressed. For the prostate
c a n c e r  d a t a  s e t ,  a  P-value for differential expression
between the treated and untreated cells was obtained for
each gene using a Poisson exact test, equivalent to
Fisher's exact test [15-17]. These P-values were then cor-
rected for multiple testing [18] and the false discovery
rate was set at 10-4. Figure 2a shows a plot of the propor-
tion of DE genes as a function of length. A strong trend
towards a higher rate of differential expression for genesYoung et al. Genome Biology 2010, 11:R14
http://genomebiology.com/2010/11/2/R14
Page 3 of 12
with longer transcripts is evident. Figure 2b shows a simi-
lar trend towards more differential expression for genes
wit h a highe r t otal  n um be r of  r eads.  As e x pect ed,  t he
trend is stronger for total read count compared to tran-
script length. Other statistical methods for determining
differential expression between samples show a similar
trend of increasing proportion of DE genes with gene
length, even when working with data normalized by
dividing by transcript length, such as RPKM transformed
data [19] (Figure S1b,c in Additional file 1). Non-statisti-
cal methods for determining DE, such as using a fold-
change cutoff, can show a decreasing trend in the propor-
tion of DE as a function of gene length (Figure S1a in
Additional file 1). Any trend observed in the data is mod-
eled by the second step of the GOseq procedure.
In the second step, a probability weighting function
(PWF) is estimated from the data. The PWF quantifies
how the probability of a gene selected as DE changes as a
function of its transcript length. To estimate this trend
function, each gene is assigned a binary value (zero or
one), according to whether or not the gene is found to be
DE. A monotonic spline with 6 knots is then fitted to this
binary data series using the transcript length of each gene
as predictor (see Materials and methods). Monotonicity
is imposed as the power to detect DE using statistical
tests increases monotonically with an increasing number
of reads. Figure 2 also shows the resulting probability
weighting function for the prostate cancer data set. The
PWF then forms the null hypothesis for our enrichment
test.
Unlike GO analysis for microarray data, the null proba-
bility distribution does not conform to a standard distri-
bution, precluding an analytical solution for determining
the probability of a category being over-represented
among DE genes. However, the P-value for each category
can be computed using a resampling strategy. For the
final step of the GOseq method, resampling was per-
formed by randomly selecting a set of genes, the same
size as the set of DE genes, and counting the number of
genes associated with the GO category of interest. This
random selection weights the chance of choosing a gene
by its  le ngt h o r r ea d c oun t, fr om  t he  pr evi ous ly  fit t ed
probability weighting function. The resampling is
repeated many times and the resulting distribution of GO
category membership is taken to approximate the shape
of the true probability distribution. This sampling distri-
bution allows calculation of a P-value for each GO cate-
gory being over-represented in the set of DE genes while
taking selection bias into account.
Length distribution of genes in Gene Ontology categories
Figure 1 Length distribution of genes in Gene Ontology categories. (a) The distribution of average gene lengths in GO categories on a log10 
scale. The GO category gene length is given by the median length of the genes within the category. (b) P-values for the two-sided Mann-Whitney U 
test comparing the median length of genes in a GO category with the overall distribution of genes for 7,873 GO categories. The excess of low P-values 
shows that there are many GO categories that contain a set of significantly long or short genes.
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The Wallenius approximation
Although accurate, random sampling is very computa-
tionally intensive, particularly when a fine granularity in
P-value is needed to distinguish between large numbers
of categories. In order to make the calculation in the final
step of the GOseq procedure computationally manage-
able, we implemented an alternative approximation tech-
nique, based on an extension of the hypergeometric
Differential expression as a function of gene length and read count
Figure 2 Differential expression as a function of gene length and read count. (a) The proportion of DE genes is plotted as a function of the tran-
script length. Each point represents the percentage of genes called DE in a bin of 300 genes plotted against the median gene length for the bin. The 
green line is the probability weighting function obtained by fitting a monotonic cubic spline with 6 knots to the binary data. A clear trend towards 
more detected differential expression at longer gene lengths can be seen. (b) The same, except instead of transcript length, the total number of reads 
for each gene was used. Again, a trend towards more DE for genes with more reads can be seen. Note the greater range of probabilities compared to 
(a).
Gene length (bases) Number of reads
0 2000 4000 6000 8000 0 500 1500 2500 3500
P
r
o
p
o
r
t
i
o
n
 
D
E
0.00
0.05
0.10
0.15
0.20
0.25
0.30
P
r
o
p
o
r
t
i
o
n
 
D
E
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
(a) (b)
Table 1: Gene Ontology categories ranked in the top 25 in the standard method but not in length bias adjusted GOseq
GOID Term Ontology Rank standard Rank GOseq Average gene 
length in 
category
GO:0005622 Intracellular CC 9 38 2,710
GO:0005524 ATP binding MF 12 113 3,133
GO:0008270 Zinc ion binding MF 13 145 2,817
GO:0016020 Membrane CC 16 702 2,571
GO:0046872 Metal ion binding MF 17 255 2,734
GO:0006355 Regulation of 
transcription, 
DNA-dependent
BP 19 266 2,752
GO:0000139 Golgi membrane CC 22 28 2,855
GO:0016740 Transferase 
activity
MF 25 116 2,721
The median gene length of all categories are significantly longer than average using a Mann-Whitney test. BP, biological process; CC, cellular 
component; MF, molecular function.Young et al. Genome Biology 2010, 11:R14
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distribution known as the Wallenius non-central hyper-
geometric distribution [20]. This distribution extends the
hypergeometric distribution to the case where the proba-
bility of success and failure differ. The GOseq implemen-
tation of the approximation assumes that all genes within
a category have the same probability of being chosen, but
this probability is different from the probability of choos-
ing genes outside this category. The mean of the probabil-
ity weightings for each gene within/outside the category
is defined as the common probability of choosing a gene
within/outside that category. While the Wallenius
approximation is obviously a simplification, it is signifi-
cantly closer to the true distribution than the standard
hypergeometric distribution.
Although the accuracy lost by using the Wallenius
approximation is not negligible, the gain in computa-
tional efficiency is dramatic. Furthermore, the ability to
differentiate the most highly over-represented categories
from one another (Additional file 1) makes the Wallenius
approximation an attractive alternative, particularly when
the range of the probability weighting function is moder-
ate.
Comparisons of GOseq with the standard GO analysis
To compare the results from the GOseq procedure to the
standard GO analysis used on microarray data, we
applied both methods to the prostate cancer data set. For
each method a list of GO categories ordered by signifi-
cance was generated. Figure 3 compares the ranks of the
GO categories between the GOseq method and hyper-
geometric method as a function of gene length (Figure
3a) or total read count (Figure 3b) within categories. As
expected, categories with shorter than average length
move up in rank (become more significant) when length
bias has been taken into account with the GOseq method.
Similarly, categories with longer than average genes are
ranked lower by GOseq than the standard method. Fur-
thermore, when accounting for gene length bias, of the 25
categories most significantly over-represented using
GOseq and the standard method, 8 are discrepant
between the methods (Tables 1 and 2). This highlights the
fact that accounting for biases in detecting DE makes a
significant difference to the biology identified from the
results.
The standard GOseq analysis was also compared to
both the random sampling strategy and the more compu-
tationally efficient Wallenius approximation. P-values for
Table 2: Gene Ontology categories ranked in the top 25 in length bias adjusted GOseq but not in the standard method
GOID Term Ontology Rank standard Rank GOseq Average gene 
length in 
category
GO:0006414 Translational 
elongation
BP 92 8 708*
GO:0000786 Nucleosome CC 64 14 1,345*
GO:0006334 nucleosome 
assembly
BP 70 17 1,362*
GO:0043687 Post-translational 
protein 
modification
BP 50 20 1,830
GO:0019787 Small conjugating 
protein ligase 
activity
MF 65 25 1,928
GO:0016192 Vesicle-mediated 
transport
BP 28 22 2,765
GO:0006412 Translation BP 104 23 1,472
GO:0051246 Regulation of 
protein metabolic 
process
BP 66 24 1,609
Three of these categories (marked with asterisks) have genes significantly shorter than average length (Mann-Whitney P-value < 0.05). BP, 
biological process; CC, cellular component; MF, molecular function.Young et al. Genome Biology 2010, 11:R14
http://genomebiology.com/2010/11/2/R14
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over-representation of DE genes for each GO category
were generated using random sampling with a high num-
ber of repetitions (200,000). These P-values were then
compared to P-values calculated using the standard
hypergeometric test and GOseq utilizing the Wallenius
approximation. Comparison of the categories' P-values
demonstrate a large discrepancy between the GOseq
method and the hypergeometric method, as well as very
little difference between GOseq using sampling or Walle-
nius (Figure 4a; Figure S3 in Additional file 1). Further-
more, we compared the top ranked lists of enriched GO
categories between two methods by plotting the number
of discrepancies between the methods for a given list size
(Figure 4b). This plot shows that for the prostate cancer
data set, approximately 20% of GO categories that appear
using the standard analysis are not present when GOseq
is used and vice versa. The high number of discrepancies
for short lists shows that failure to account for length bias
impairs analysis, even if we are only interested in a small
number of categories. Reassuringly, the Wallenius
approximation closely approximates GOseq using high
repetition sampling with very few changes in P-values or
rankings of categories. Similar results are seen for other
RNA-seq datasets (data not shown).
Measuring GOseq's accuracy by comparison with 
microarray data
The GOseq method clearly makes a substantial difference
to the categories selected when performing a GO analy-
sis. In order to demonstrate that accounting for length
b i a s  p r o d u c e s  m o r e  r e l i a b l e  r e s u l t s ,  w e  c o m p a r e d  t h e
results of GOseq and the standard test to the GO analysis
from a microarra y e xperiment that does not show any
gene length bias [5]. For the comparison of RNA-seq and
microarrays, a data set was used that compares the exact
same liver and kidney samples on the two platforms [21]
(see Materials and methods). Figure 5 plots the fraction of
microarray GO categories recovered from the RNA-seq
data using the hypergeometric and GOseq methods, as a
function of the number of GO categories considered. It
can be seen that GOseq gives categories more consistent
with the microarray platform (P = 0.067), indicating that
accounting for length bias gives a GO analysis with better
performance.
Transcript length bias versus read count bias
As transcript length bias is a technical effect, it is always
necessary to correct for it when performing category test-
ing on RNA-seq data. However, the bias in power to
detect DE in longer genes arises from an increase in the
total number of reads for each gene, where the number of
Change in Gene Ontology category rank between the standard and GOseq methodologies
Figure 3 Change in Gene Ontology category rank between the standard and GOseq methodologies. (a) Change in rank of GO categories go-
ing from the hypergeometric method to GOseq correcting for length bias plotted against the log of the average gene length of the category. (b) 
Change in rank of GO categories going from the hypergeometric method to GOseq correcting for total read count plotted against the log of the av-
erage number of counts of each gene in the category. A trend for the standard method to underestimate significance for GO categories containing 
short (or highly expressed) genes and overestimate significance for GO categories containing long (or underexpressed) genes can be clearly seen.
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reads is given by transcript length multiplied by expres-
sion level. Therefore, there may be circumstances where
it is desirable to correct for the effect of expression level
on power to detect DE, in addition to the contribution
from transcript length, that is, total read count bias (for
further discussion see Additional file 1). The GOseq
method is capable of handling both types of bias. We have
mainly focused on transcript length bias as it will always
need to be accounted for and because the decision to
account for expression level or not ultimately depends on
the questions the user wishes to answer.
To assess the impact of total read count bias, GOseq
was used to analyze the prostate cancer data set account-
ing for read count bias. As expected, correcting for read
count bias results in even greater differences compared to
the standard hypergeometric method than just correcting
for length bias alone. When read count bias is corrected
for in the prostate cancer data set, more than 50% of sig-
nificant GO categories are different from the list of signif-
icant GO categories obtained using the standard
hypergeometric method (Figure 6). This is true even for
the very top GO categories - there is only one GO cate-
gory that appears in the top ten in both the standard and
read count adjusted lists (Tables 3 and 4).
Discussion
Biological relevance of selected categories
To determine the effect of GOseq on the ability to draw
biologically meaningful conclusions, the top ten GO cate-
gories using the standard hypergeometric method and
the read count adjusted GOseq method were compared
in the prostate cancer data set (Tables 3 and 4). We found
that categories identified by GOseq are more consistent
with previous studies looking at the relationship of
androgens with prostate cancer. The role of androgens in
prostate cancer is well supported, with androgen required
in rodent prostate cancer induction models, and castra-
tion prior to puberty being protective against prostate
cancer. Androgen is thought to be responsible for promo-
tion of prostate cancer progression through enhancing
the androgen regulated processes of growth and cellular
activity. In normal prostate, androgen supports the secre-
tary epithelial, which turns over at a rate of 1 to 2% of
cells per day, and most prostate cancers are derived from
these cells [22]. Based on this biological knowledge the
prior expectation is that there will be an increase in cellu-
lar activity, proliferation and secretion in LNCaP cells in
response to androgen. Previous microarray experiments
have shown that LNCaP cells retain androgen responsive-
ness and that most genes upregulated are involved in the
production of seminal fluid [23].
In the standard analysis, the top ten GO categories
indicate a change in intracellular genes, including nuclear
and DNA binding genes (Table 3). The top ten categories
using GOseq with total read count adjustment indicate
significant changes at membranes and extracellular space,
transcriptional upregulation, and in cell cycle genes
(Table 4). The categories identified as most significant by
GOseq therefore better match the known biology of
androgen response in prostate cancer. The genes that are
significant only with the length bias adjustment (Table 2)
include four categories consistent with increased transla-
tion and protein production, vesical mediated transport
consistent with secretion, and two categories related to
Table 3: Top ten Gene Ontology categories using the standard method
GOID Term Ontology Rank standard Rank GOseq Median read 
count of genes in 
category
GO:0005515 Protein binding MF 1 11 206
GO:0005737 Cytoplasm CC 2 111 238
GO:0005634 Nucleus CC 3 4,303 228
GO:0000166 Nucleotide 
binding
MF 4 2,546 252
GO:0005829 Cytosol CC 5 1,192 349
GO:0005783 Endoplasmic 
reticulum
CC 6 6 197
GO:0003677 DNA binding MF 7 2,109 189
GO:0005794 Golgi apparatus CC 8 26 213
GO:0005622 Intracellular CC 9 3,592 187
GO:0016874 Ligase activity MF 10 88 353
BP, biological process; CC, cellular component; MF, molecular function.Young et al. Genome Biology 2010, 11:R14
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nucleosomes consistent with increased replication. The
category of small conjugating protein ligase activity is
supported by the previously reported up-regulation of
ubiquitin ligases UBE2C and HSPC150 [23].
Possibility of true biological trends in gene length
A key assumption of GOseq is that longer genes are not
of biologically greater interest than shorter genes, per se.
This assumption is supported by microarray data, where
no systematic trend between gene length and differential
expression has been observed [5]. The authors find it
hard to imagine that any genuine biological process could
induce a trend in differential expression versus gene
length comparable in magnitude to the technical trend
that is removed by GOseq. Nevertheless, users should be
aware that any biological trend in DE versus gene length
will be adjusted for by GOseq.
Using the Wallenius approximation
The reduction in computation afforded by the Wallenius
approximation is predicated on the assumption that the
variance in the probability weighting within categories is
low. Hence, the approximation will perform better for a
probability weighting function with a low range of proba-
bilities. When the range in probabilities as a function of
gene length or read count is large, random sampling per-
forms better than the Wallenius approximation, even at a
relatively small number of replicates. The probability
weighting function for read count bias has a larger range
in probabilities compared to the PWF for length bias in
the prostate cancer data set (Figure 2) and so random
sampling may be more appropriate when accounting for
total read count bias.
GOseq and other technologies
GOseq with total read count adjustment is relevant for
other tag-based next generation expression profiling
Table 4: Top ten Gene Ontology categories using GOseq adjusted for total read count bias
GOID Term Ontology Rank standard Rank GOseq Median read 
count of genes in 
category
GO:0016020 Membrane CC 16 1 91
GO:0005886 Plasma 
membrane
C C 9 625 0
GO:0005887 Integral to plasma 
membrane
CC 313 3 36
GO:0005576 Extracellular 
region
CC 4,310 4 18
GO:0015020 Glucuronosyl 
transferase 
activity
MF 388 5 10
GO:0005783 Endoplasmic 
reticulum
CC 6 6 197
GO:0016021 Integral to 
membrane
CC 179 7 68
GO:0006470 Protein amino 
acid 
dephosphorylatio
n
BP 31 8 224
GO:0045944 Positive 
regulation of 
transcription from 
RNA polymerase II 
promoter
BP 39 9 133
GO:0007049 Cell cycle BP 14 10 202
BP, biological process; CC, cellular component; MF, molecular function.Young et al. Genome Biology 2010, 11:R14
http://genomebiology.com/2010/11/2/R14
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technologies, such as SAGE or CAGE, which have no
transcript length bias [24]. Even without length bias, sta-
tistical power to detect differential expression still
depends on the expression level of each transcript and
correcting for this bias will generally be desirable in this
context.
GO analysis of microarray expression data has so far
ignored the possibility of selection bias, but such bias
clearly does exist. It is well known that fold changes are
more precisely estimated for microarray probes at higher
intensity levels, so selection bias is likely to exist as a
function of intensity. Furthermore, most microarray plat-
forms have multiple probes for some genes. Genes with
more probes will have a great chance of being selected as
DE, assuming the analysis is conducted probe-wise. The
methodology developed here for RNA-seq could easily be
adapted to GO analysis of microarray data, and would
likely yield benefits in terms of biological relevance.
GOseq software
In order to implement the GOseq method, we developed
a set of freely available R functions, which includes func-
tions for calculating the significance of over-representa-
tion of each GO category amongst DE genes. These
functions give the user the option of selecting which type
of bias they wish to compensate for (transcript length
bias or total read count bias). The option of using random
sampling or the Wallenius approximation is also avail-
able. The ability of the user to supply their own categories
for unbiased testing is also included. The software is
freely available and can be downloaded from our website
[25].
Conclusions
Here we have developed a statistical framework for GO
analysis for use with RNA-seq data. It is mathematically
indisputable that all commonly used criteria for judging
DE interact with gene length and read count. This pro-
vides a well understood causal model of why length bias
exists and why it needs to be accounted for. The GOseq
method is able to account for such biases when perform-
ing GO analysis. We find that the new method makes a
substantial difference to the categories identified as the
most significant. We show that the GOseq method is able
to recover well established microarray results more read-
i l y  t h a n  e x i s t i n g  m e t h o d s  o f  G O  a n a l y s i s  o f  R N A - s e q
data. Furthermore, using an androgen treated prostate
cancer data set we find that the most significant catego-
ries identified using GOseq match the known biology
better than existing methods.
Materials and methods
All the statistical analyses were performed in R [26]. The
methods are described in detail in Additional file 1 and
outlined briefly here.
Comparison of GOseq and the standard hypergeometric methods
Figure 4 Comparison of GOseq and the standard hypergeometric methods. (a) The P-values generated with GOseq using the Wallenius approx-
imation and the standard hypergeometric method are plotted against the P-values calculated with GOseq using random sampling (200k repeats). The 
Wallenius method (green crosses) shows good agreement with the high resolution (200,000 repeats) random sampling. A large discrepancy in P-val-
ues is seen between GOseq and the hypergeometric method. (a) The number of discrepancies between lists is shown for a given list size. The black 
line compares GOseq using high resolution sampling with the hypergeometric method. The red line compares GOseq using high resolution sampling 
with the Wallenius approximation. Again, GOseq using the Wallenius method shows little difference from GOseq using the random sampling method 
(with 200k repeats) while the hypergeometric method shows a large number (approximately 20%) of discrepancies.
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The prostate cancer data set
The LNCap cell line was treated with androgen. Mock
treated and treated cell lines were sequenced using the
Illumina GA 1 [13]. Raw 35-bp RNA-seq reads were pro-
vided and mapped to the human genome using Bowtie.
E a c h  m a p p e d  r e a d  w a s  a s s o c i a t e d  w i t h  a n  E N S E M B L
gene. A Poisson exact test [15,16] was used to determine
differential expression between treated and mock-treated
LNCap cells.
The liver versus kidney data set
Genome-wide expression was measured in liver and kid-
ney using RNA-seq on the Illumina GA I and hybridiza-
tion of the same samples to Affymetrix HG-U133 Plus 2.0
arrays. The sample preparation and data analysis was
designed to maximize the similarity between the
microarray and RNA-seq experiments (see Marioni et al.
[21]). Differential expression between kidney and liver
was determined using an empirical Bayes modified t-sta-
tistic on the microarray platform and P-values for DE
were downloaded from their website. For the RNA-seq
experiment, the data were normalized using TMM nor-
malization [27] and a negative binomial exact test was
used to determine DE [16]. To test the GOseq method,
we used the genes called DE from the microarray experi-
ment to calculate the significance of over-representation
of each GO category using the standard GO analysis
methods. We also calculated P-values for each GO cate-
gory being over-represented among genes that were DE
in the RNA-seq data, using both the GOseq and hyper-
geometric methods. GOseq's ability to outperform the
hypergeometric method, as measured by its ability to
reproduce the results of the microarray GO analysis, was
quantified by calculating a P-value for the difference in
the two methods being due to chance. To do this, a NULL
was chosen under which both methods were equally
likely to correctly recover each microarray GO category,
with this likelihood given by a binomial distribution.
The probability weighting function
To calculate the PWF, a cubic spline with a montonicity
constraint is fitted to the binary data series where a value
of 1 refers to a DE gene and 0 refers to a non-DE gene.
This fit can be calculated against either the length of the
gene or the read counts of a gene. We used the R function
pcls in the mgcv package to generate the fit.
Calculating significance of categories
Random samples of genes are created by selecting a sub-
set of genes from the experiment, with each gene
weighted by the probability derived from the PWF. Each
random sample contains the same number of genes as the
set of DE genes. For each sample the number of genes
with a given GO category is calculated. Many samples are
generated in order to produce a null distribution from
A comparison of Gene Ontology analysis using RNA-seq and mi-
croarrays on the same samples
Figure 5 A comparison of Gene Ontology analysis using RNA-seq 
and microarrays on the same samples. The fraction of GO categories 
identified by RNA-seq data that overlap with the microarray GO analy-
sis are shown as a function of the number of categories selected. RNA-
seq data have been analyzed using GOseq and hypergeometric meth-
ods. The GOseq categories have a consistently higher overlap with the 
microarray GO categories than the standard method.
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which the P-value for the significance of a category can
be estimated.
To implement the Wallenius approximation, we used
the BiasedUrn package in R. The 'odds' parameter is
defined as the relative probability of genes within a cate-
gory to the genes outside the category. The 'odds' ratio is
calculated by taking the mean of the values from the PWF
for each gene in the set and dividing by the mean of the
values from the PWF for genes outside the set.
Additional material
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DE: differentially expressed; GO: Gene Ontology; PWF: probability weighting
function.
Authors' contributions
AO, GKS, and MJW conceived of the idea. AO, MDY, and GKS conceived and
performed the analysis. MDY wrote the software. MJW interpreted biological
results. MDY, MJW, GKS, and AO wrote the paper. All authors read and approved
the final manuscript.
Acknowledgements
We thank Mark Robinson for providing insightful discussion and some R code 
and to Yoav Gilad for critical reading of the manuscript. We thank Gene Yeo 
and Michael Lovci for providing raw RNA-seq data.
Author Details
Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, 
1G Royal Parade, Parkville 3052, Australia
References
1. Fu X, Fu N, Guo S, Yan Z, Xu Y, Hu H, Menzel C, Chen W, Li Y, Zeng R, 
Khaitovich P: Estimating accuracy of RNA-Seq and microarrays with 
proteomics.  BMC Genomics 2009, 10:161.
2. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore 
SF, Schroth GP, Burge CB: Alternative isoform regulation in human 
tissue transcriptomes.  Nature 2008, 456:470-476.
3. Wang X, Sun Q, McGrath SD, Mardis ER, Soloway PD, Clark AG: 
Transcriptome-wide identification of novel imprinted genes in 
neonatal mouse brain.  PloS One 2008, 3:e3839.
4. Wahlstedt H, Daniel C, Enstero M, Ohman M: Large-scale mRNA 
sequencing determines global regulation of RNA editing during brain 
development.  Genome Res 2009, 19:978-986.
5. Oshlack A, Wakefield MJ: Transcript length bias in RNA-seq data 
confounds systems biology.  Biol Direct 2009, 4:14.
6. Zhou X, Su Z: EasyGO: Gene Ontology-based annotation and functional 
enrichment analysis tool for agronomical species.  BMC Genomics 2007, 
8:246.
7. Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, Sunshine M, Narasimhan 
S, Kane DW, Reinhold WC, Lababidi S, Bussey KJ, Riss J, Barrett JC, 
Weinstein JN: GoMiner: a resource for biological interpretation of 
genomic and proteomic data.  Genome biology 2003, 4:R28.
8. Beissbarth T, Speed TP: GOstat: find statistically overrepresented Gene 
Ontologies within a group of genes.  Bioinformatics 2004, 20:1464-1465.
9. Martin D, Brun C, Remy E, Mouren P, Thieffry D, Jacq B: GOToolBox: 
functional analysis of gene datasets based on Gene Ontology.  Genome 
Biol 2004, 5:R101.
10. Alexa A, Rahnenfuhrer J, Lengauer T: Improved scoring of functional 
groups from gene expression data by decorrelating GO graph 
structure.  Bioinformatics 2006, 22:1600-1607.
11. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, 
Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set 
enrichment analysis: a knowledge-based approach for interpreting 
genome-wide expression profiles.  Proc Natl Acad Sci USA 2005, 
102:15545-15550.
12. Huang da W, Sherman BT, Lempicki RA: Systematic and integrative 
analysis of large gene lists using DAVID bioinformatics resources.  Nat 
Protoc 2009, 4:44-57.
13. Li H, Lovci MT, Kwon YS, Rosenfeld MG, Fu XD, Yeo GW: Determination of 
tag density required for digital transcriptome analysis: application to 
an androgen-sensitive prostate cancer model.  Proc Natl Acad Sci USA 
2008, 105:20179-20184.
14. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, 
Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis 
A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G: 
Gene ontology: tool for the unification of biology. The Gene Ontology 
Consortium.  Nat Genet 2000, 25:25-29.
15. Robinson MD, Smyth GK: Moderated statistical tests for assessing 
differences in tag abundance.  Bioinformatics 2007, 23:2881-2887.
16. Robinson MD, Smyth GK: Small-sample estimation of negative binomial 
dispersion, with applications to SAGE data.  Biostatistics 2008, 
9:321-332.
17. Robinson MD, McCarthy DJ, Smyth GK: edgeR: a Bioconductor package 
for differential expression analysis of digital gene expression data.  
Bioinformatics 2009, 26:139-140.
18. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a pratical 
and powerful approach to multiple testing.  J R Stat Soc Series B 
(Methodological) 1995, 57:289-300.
19. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B: Mapping and 
quantifying mammalian transcriptomes by RNA-Seq.  Nat Methods 
2008, 5:621-628.
20. Wallenius KT: Biased sampling: the non-central hypegeometric 
probability distribution.  PhD: Stanford University; 1963. 
21. Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y: RNA-seq: an 
assessment of technical reproducibility and comparison with gene 
expression arrays.  Genome Res 2008, 18:1509-1517.
22. Feldman BJ, Feldman D: The development of androgen-independent 
prostate cancer.  Nat Rev Cancer 2001, 1:34-45.
23. DePrimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, Fero M, Tibshirani R, 
Brown PO, Brooks JD: Transcriptional programs activated by exposure 
of human prostate cancer cells to androgen.  Genome Biol 2002, 
3:RESEARCH0032.
24. t Hoen PA, Ariyurek Y, Thygesen HH, Vreugdenhil E, Vossen RH, de 
Menezes RX, Boer JM, van Ommen GJ, den Dunnen JT: Deep 
sequencing-based expression analysis shows major advances in 
robustness, resolution and inter-lab portability over five microarray 
platforms.  Nucleic Acids Res 2008, 36:e141.
25. GOseq software   [http://bioinf.wehi.edu.au/software/goseq/]
26. The R Project for Statistical Computing   [http://www.r-project.org/]
27. Robinson MD, Oshlack A: A scaling normalization method for 
differential expression analysis of RNA-seq data.  Genome Biology 2010 
in press.
28. Langmead B, Trapnell C, Pop M, Salzberg SL: Ultrafast and memory-
efficient alignment of short DNA sequences to the human genome.  
Genome Biol 2009, 10:R25.
29. Ensembl BioMart   [http://www.biomart.org]
30. Barnard GA: Contribution to the discussion of Professor Bartlet's paper.  
J Roy Stat Soc Series B (Methodological) 1963, 25:294.
31. Efraimidis P, Spirakis PG: Weighted random sampling with a reservoir.  
Information Processing Lett 2005, 97:181-185.
32. Smyth GK: Limma: linear models for microarray data.  In Bioinformatics 
and Computational Biology Solutions using R and Bioconductor Edited by: 
Gentleman R, Care V, Dudoit S, Irizarry R, Huber W. New York: Springer; 
2005:397-420. 
Additional file 1
A Word document containing supplementary methods, discussion and 
results. Particular attention is given to technical details of the GOseq 
method.
Received: 1 December 2009 Revised: 14 January 2010 
Accepted: 4 February 2010 Published: 4 February 2010
This article is available from: http://genomebiology.com/2010/11/2/R14 © 2010 Young et al.; licensee BioMed Central Ltd.  This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Genome Biology 2010, 11:R14Young et al. Genome Biology 2010, 11:R14
http://genomebiology.com/2010/11/2/R14
Page 12 of 12
doi: 10.1186/gb-2010-11-2-r14
Cite this article as: Young et al., Gene ontology analysis for RNA-seq: 
accounting for selection bias Genome Biology 2010, 11:R14